Pelthos Therapeutics PTHS
NYSE PTHS
$25.51 -1.15 (-4.31%)
At close: Aug 21, 2026 · 4:00 PM EDT

Pelthos Therapeutics (PTHS) Goodwill & Intangibles (2025 - 2026)

Pelthos Therapeutics (PTHS) posted quarterly Goodwill & Intangibles of $64.2 million for Q4 2025, up 1.59% quarter-over-quarter from $63.1 million in Q3 2025.

Pelthos Therapeutics (PTHS) Goodwill & Intangibles (2025 - 2026) Analysis & Trends

Pelthos Therapeutics' Goodwill & Intangibles history runs 1 years deep, the most recent figure standing at $64.2 million for Q4 2025.

  • In Q4 2025, Goodwill & Intangibles changed N/A year-over-year to $64.2 million; the TTM figure through Dec 2025 stood at $64.2 million (changed N/A YoY), while the FY2025 annual figure was $64.2 million, changed N/A from the prior year.
  • Goodwill & Intangibles for Q4 2025 stood at $64.2 million, up from $63.1 million in the prior quarter.
  • The five-year high for Goodwill & Intangibles was $64.2 million in Q4 2025, with the low at $63.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Pelthos Therapeutics 91.09 Mn 66.53 Mn 21.23 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 62.08 Mn
Dec 31, 2025 64.15 Mn
Sep 30, 2025 63.15 Mn